Nasdaq
REPL
Replimune Group, Inc.
- Health Care
- Listed 2018
- 1 day
- +8.7%
- 1 month
- +11.7%
- 1 year
- +134%
$12.86 · Mkt cap $1.08B
At the 6 Aug 2026 close
Nasdaq
Replimune Group, Inc.
$12.86 · Mkt cap $1.08B
At the 6 Aug 2026 close
Replimune Group, Inc. trades under the ticker REPL on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2018. Its market capitalisation is $1.08B. The last closing price was $12.86, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +134%, and +11.7% over the past month. Returns are price returns and exclude dividends.
This page exists because REPL is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.